Follow
Lakshmi Reddy Bollu
Lakshmi Reddy Bollu
Verified email at northwestern.edu
Title
Cited by
Cited by
Year
Gain of glucose-independent growth upon metastasis of breast cancer cells to the brain
J Chen, HJ Lee, X Wu, L Huo, SJ Kim, L Xu, Y Wang, J He, LR Bollu, ...
Cancer research 75 (3), 554-565, 2015
1682015
Molecular pathways: targeting protein tyrosine phosphatases in cancer
LR Bollu, A Mazumdar, MI Savage, PH Brown
Clinical Cancer Research 23 (9), 2136-2142, 2017
1452017
Immunosuppressive IDO in cancer: mechanisms of action, animal models, and targeting strategies
L Zhai, A Bell, E Ladomersky, KL Lauing, L Bollu, JA Sosman, B Zhang, ...
Frontiers in immunology 11, 1185, 2020
1442020
Transcriptional regulation of core autophagy and lysosomal genes by the androgen receptor promotes prostate cancer progression
AM Blessing, K Rajapakshe, L Reddy Bollu, Y Shi, MA White, AH Pham, ...
Autophagy 13 (3), 506-521, 2017
1102017
ATP citrate lyase mediates resistance of colorectal cancer cells to SN38
Y Zhou, LR Bollu, F Tozzi, X Ye, R Bhattacharya, G Gao, E Dupre, L Xia, ...
Molecular cancer therapeutics 12 (12), 2782-2791, 2013
922013
Antiproliferative effects and mechanisms of liver X receptor ligands in pancreatic ductal adenocarcinoma cells
NR Candelaria, S Addanki, J Zheng, T Nguyen-Vu, H Karaboga, P Dey, ...
PloS one 9 (9), e106289, 2014
632014
Tumor cell IDO enhances immune suppression and decreases survival independent of tryptophan metabolism in glioblastoma
L Zhai, A Bell, E Ladomersky, KL Lauing, L Bollu, B Nguyen, M Genet, ...
Clinical cancer research 27 (23), 6514-6528, 2021
602021
Intracellular activation of EGFR by fatty acid synthase dependent palmitoylation
LR Bollu, RR Katreddy, AM Blessing, N Pham, B Zheng, X Wu, Z Weihua
Oncotarget 6 (33), 34992, 2015
582015
Involvement of de novo synthesized palmitate and mitochondrial EGFR in EGF induced mitochondrial fusion of cancer cells
LR Bollu, J Ren, AM Blessing, RR Katreddy, G Gao, L Xu, J Wang, F Su, ...
Cell cycle 13 (15), 2415-2430, 2014
572014
SOX9 is essential for triple-negative breast cancer cell survival and metastasis
Y Ma, J Shepherd, D Zhao, LR Bollu, WM Tahaney, J Hill, Y Zhang, ...
Molecular Cancer Research 18 (12), 1825-1838, 2020
512020
EGFR–SGLT1 interaction does not respond to EGFR modulators, but inhibition of SGLT1 sensitizes prostate cancer cells to EGFR tyrosine kinase inhibitors
J Ren, LR Bollu, F Su, G Gao, L Xu, WC Huang, MC Hung, Z Weihua
The Prostate 73 (13), 1453-1461, 2013
472013
Glioblastoma as an age-related neurological disorder in adults
M Kim, E Ladomersky, A Mozny, M Kocherginsky, K O’Shea, ZZ Reinstein, ...
Neuro-oncology advances 3 (1), vdab125, 2021
462021
A retrospective survival analysis of Glioblastoma patients treated with selective serotonin reuptake inhibitors
S Otto-Meyer, R DeFaccio, C Dussold, E Ladomersky, L Zhai, KL Lauing, ...
Brain, Behavior, & Immunity-Health 2, 100025, 2020
312020
Targeted reduction of the EGFR protein, but not inhibition of its kinase activity, induces mitophagy and death of cancer cells through activation of mTORC2 and Akt
RR Katreddy, LR Bollu, F Su, N Xian, S Srivastava, R Thomas, Y Dai, ...
Oncogenesis 7 (1), 5, 2018
312018
Identification of a novel coregulator, SH3YL1, that interacts with the androgen receptor N-terminus
AM Blessing, S Ganesan, K Rajapakshe, Y Ying Sung, L Reddy Bollu, ...
Molecular endocrinology 29 (10), 1426-1439, 2015
302015
Sodium/glucose co-transporter 1 expression increases in human diseased prostate
A Blessing, L Xu, G Gao, LR Bollu, J Ren, H Li, X Wu, F Su, WC Huang, ...
J Cancer Sci Ther 4 (9), 306-312, 2012
232012
Mutant P53 induces MELK expression by release of wild-type P53-dependent suppression of FOXM1
LR Bollu, J Shepherd, D Zhao, Y Ma, W Tahaney, C Speers, A Mazumdar, ...
NPJ Breast cancer 6 (1), 2, 2020
202020
The phosphatase PPM1A inhibits triple negative breast cancer growth by blocking cell cycle progression
A Mazumdar, WM Tahaney, L Reddy Bollu, G Poage, J Hill, Y Zhang, ...
NPJ Breast Cancer 5 (1), 22, 2019
192019
Alcohol regulates genes that are associated with response to endocrine therapy and attenuates the actions of tamoxifen in breast cancer cells
NR Candelaria, R Weldon, S Muthusamy, T Nguyen-Vu, S Addanki, ...
PLoS One 10 (12), e0145061, 2015
182015
Identification and characterization of a novel indoleamine 2, 3-dioxygenase 1 protein degrader for glioblastoma
LR Bollu, PV Bommi, PJ Monsen, L Zhai, KL Lauing, A Bell, M Kim, ...
Journal of Medicinal Chemistry 65 (23), 15642-15662, 2022
112022
The system can't perform the operation now. Try again later.
Articles 1–20